169 related articles for article (PubMed ID: 23382603)
61. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
[TBL] [Abstract][Full Text] [Related]
62. High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia.
Costa D; Queralt R; Aymerich M; Carrió A; Rozman M; Vallespí T; Colomer D; Nomdedeu B; Montserrat E; Campo E
Cancer Genet Cytogenet; 2003 Nov; 147(1):36-43. PubMed ID: 14580769
[TBL] [Abstract][Full Text] [Related]
63. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
[TBL] [Abstract][Full Text] [Related]
64. De novo CD5+ Burkitt lymphoma/leukemia.
Lin CW; O'Brien S; Faber J; Manshouri T; Romaguera J; Huh YO; Kantarjian H; Keating M; Albitar M
Am J Clin Pathol; 1999 Dec; 112(6):828-35. PubMed ID: 10587706
[TBL] [Abstract][Full Text] [Related]
65. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
66. Prolymphocytic leukemias.
Krishnan B; Matutes E; Dearden C
Semin Oncol; 2006 Apr; 33(2):257-63. PubMed ID: 16616073
[TBL] [Abstract][Full Text] [Related]
67. [Prolymphocytic leukemia].
Dietrich PY; Pedraza E; Bayle C; Pico JL; Hayat M
Bull Cancer; 1991; 78(9):801-6. PubMed ID: 1751831
[TBL] [Abstract][Full Text] [Related]
68. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
[TBL] [Abstract][Full Text] [Related]
69. Prolymphocytic leukemia: histologic findings in atypical cases.
Owens MR; Strauchen JA; Rowe JM; Bennett JM
Hematol Oncol; 1984; 2(3):249-57. PubMed ID: 6592135
[TBL] [Abstract][Full Text] [Related]
70. T-cell prolymphocytic leukemia: a single-institution experience.
Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
[TBL] [Abstract][Full Text] [Related]
71. Long-term remission of T-lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogeneic bone marrow transplantation.
Montefusco E; Mauro FR; Lo Coco F; Rondinelli B; Arcese W; Tabilio A; Monarca B; Alimena G; Mandelli F
Haematologica; 1990; 75(4):391-3. PubMed ID: 2276682
[TBL] [Abstract][Full Text] [Related]
72. Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia.
Wong KF; So CC; Chan JK
Am J Clin Pathol; 2002 Feb; 117(2):246-51. PubMed ID: 11865846
[TBL] [Abstract][Full Text] [Related]
73. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
Döhner H; Ho AD; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
J Natl Cancer Inst; 1993 Apr; 85(8):658-62. PubMed ID: 8468724
[TBL] [Abstract][Full Text] [Related]
74. T-cell prolymphocytic leukemia.
Dearden CE
Med Oncol; 2006; 23(1):17-22. PubMed ID: 16645226
[TBL] [Abstract][Full Text] [Related]
75. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
[TBL] [Abstract][Full Text] [Related]
76. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.
Pawson R; Dyer MJ; Barge R; Matutes E; Thornton PD; Emmett E; Kluin-Nelemans JC; Fibbe WE; Willemze R; Catovsky D
J Clin Oncol; 1997 Jul; 15(7):2667-72. PubMed ID: 9215839
[TBL] [Abstract][Full Text] [Related]
77. A case of T cell prolymphocytic leukemia involving blast transformation.
Ichikawa K; Noguchi M; Imai H; Sekiguchi Y; Wakabayashi M; Sawada T; Komatsu N
Int J Hematol; 2011 May; 93(5):667-672. PubMed ID: 21505955
[TBL] [Abstract][Full Text] [Related]
78. Prolymphocytic transformation of lymphoplasmacytic lymphoma: an extremely unusual event.
Zhang K; Farrell D; Jeyakumar D; O'Brien S; Zhao X; Rezk SA
Hum Pathol; 2019 Aug; 90():106-110. PubMed ID: 30342054
[TBL] [Abstract][Full Text] [Related]
79. B-cell prolymphocytic leukemia expressing discordant myeloid-associated antigens in simultaneous specimens from bone marrow and peripheral blood.
Emery CL; Cleveland RP
Cytometry; 1995 Sep; 22(3):243-9. PubMed ID: 8556956
[TBL] [Abstract][Full Text] [Related]
80. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
